Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adversecardiovasculareventsandvenousthromboembolism in the first year of therapy

Journal article

Open access

Peer reviewed

Jesse Ory, Sirpi Nackeeran, Navin Balaji, Joshua M. Hare, Ranjith Ramasamy and Rodrigo Barros

International Brazilian journal of urology, Vol.49(1), pp.150-151

2023-01-01

PMID: 36512463

Abstract

Life Sciences & Biomedicine

Science & Technology

Urology & Nephrology

url

https://www.scielo.br/j/ibju/a/zXP8JCdxgFxsWKQksjLXmXK/?lang=en&format=pdfView

Published (Version of record) Open

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.141 Hormone Therapy; 1.141.1092 Testosterone
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adversecardiovasculareventsandvenousthromboembolism in the first year of therapy
Creators: Jesse Ory - University of Miami, UMMG Department of Urology
Sirpi Nackeeran - University of Miami
Navin Balaji (Author) - University of Miami Miller School of Medicine
Joshua M. Hare - University of Miami, Interdisciplinary Stem Cell Institute
Ranjith Ramasamy - University of Miami, UMMG Department of Urology
Rodrigo Barros - Hospital Universitário Antônio Pedro
Publication Details: International Brazilian journal of urology, Vol.49(1), pp.150-151
Publisher: Brazilian Soc Urol
Number of pages: 2
Academic Unit: UMMG Department of Urology; Miller School of Medicine; Leadership Department; Interdisciplinary Stem Cell Institute
Language: English
Resource Type: Journal article
PMID: 36512463
Record Identifier: 991031772707302976